IndraLab

Statements


| 1 1

eidos
"Mechanistically , we found that irbesartan decreased c-Jun expression by inhibiting the Hippo / YAP1 pathway and further overcame chemotherapy resistance in PDAC ."

sparser
"Thus, inhibition of FOS and JUN by Nadroparin and Irbesartan may have potential applications as anti-inflammatory options for RSV infection."